This site is intended for healthcare professionals

Phase III edaravone post-hoc analysis of Radicut shows risk reduction in amyotrophic lateral sclerosis.- Mitsubishi Tanabe

Read time: 1 mins
Last updated:19th Mar 2021
Published:19th Mar 2021
Condition: Amyotrophic Lateral Sclerosis/Lou Gehrig's Diseas
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest